User login
LAS VEGAS – Pulsed dye lasers have stood the test of time for treating vascular malformations, rosacea, and telangectases, Dr. Christopher Zachary said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
However, Dr. Zachary noted in an interview at the meeting that the field of laser therapy is on the cusp of new innovation, not only in devices, but also in how the devices are used. Different wavelengths and combination treatments will provide more options for patients, he explained. “These are great times for those who are interested in treating vascular problems,” he said.
Dr. Zachary disclosed serving as a consultant for Cutera and Zeltiq, on the speakers bureau for Cynosure and Solta, and on the advisory board for Zeltiq.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS – Pulsed dye lasers have stood the test of time for treating vascular malformations, rosacea, and telangectases, Dr. Christopher Zachary said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
However, Dr. Zachary noted in an interview at the meeting that the field of laser therapy is on the cusp of new innovation, not only in devices, but also in how the devices are used. Different wavelengths and combination treatments will provide more options for patients, he explained. “These are great times for those who are interested in treating vascular problems,” he said.
Dr. Zachary disclosed serving as a consultant for Cutera and Zeltiq, on the speakers bureau for Cynosure and Solta, and on the advisory board for Zeltiq.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS – Pulsed dye lasers have stood the test of time for treating vascular malformations, rosacea, and telangectases, Dr. Christopher Zachary said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
However, Dr. Zachary noted in an interview at the meeting that the field of laser therapy is on the cusp of new innovation, not only in devices, but also in how the devices are used. Different wavelengths and combination treatments will provide more options for patients, he explained. “These are great times for those who are interested in treating vascular problems,” he said.
Dr. Zachary disclosed serving as a consultant for Cutera and Zeltiq, on the speakers bureau for Cynosure and Solta, and on the advisory board for Zeltiq.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
AT SDEF LAS VEGAS DERMATOLOGY SEMINAR
